Clinical Trial Update: Efficacy and Safety of Etonogestrel + 17β-Estradiol Vaginal Ring (MK-8342B) in Women With Primary Dysmenorrhea (With Optional Extension) (MK-8342B-059) [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the etonogestrel + 17β-estradiol vaginal ring for moderate-to-severe primary dysmenorrhea was terminated, and results were posted in 20…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dysmenorrhea

Drugs mentioned

• Etonogestrel + 17β-estradiol vaginal ring (MK-8342B) (etonogestrel + 17β-estradiol)

Snippet

Sponsor: Organon and Co | Conditions: Moderate to Severe Primary Dysmenorrhea | Phase 3 | Status: TERMINATED | Results posted: 2017-11-14